The SPDR Russell 1000 Low Volatility Focus ETF (ONEV) is a passively managed, smart-beta exchange-traded fund that seeks to match the performance of the Russell 1000 Low Volatility Focused Factor Index before fees and expenses. The underlying index selects large-capitalization U.S. stocks that combine core value, quality, and smaller-size characteristics with an emphasis on low volatility, then weights them with a focus on minimizing price swings.
The fund holds approximately 445–450 securities, providing broad diversification across the large-cap U.S. equity universe while deliberately tilting away from the most volatile names. Its largest individual positions include Cardinal Health (CAH), Cencora (COR), McKesson (MCK), Cognizant Technology Solutions (CTSH), and Regeneron Pharmaceuticals (REGN), with insurers such as Arch Capital Group (ACGL), Allstate (ALL), and Travelers (TRV) also featuring prominently. By sector, Industrials is the largest exposure at roughly 20% of assets, followed by Healthcare and Financials. The fund carries a net expense ratio of 0.20% and a trailing 12-month dividend yield near 1.8%.
ONEV operates within the large-cap blend segment but filters for lower-volatility, higher-quality names, which positions it as a defensive tool during periods of market uncertainty. The fund's heavy Industrials and Healthcare exposure ties it closely to steady, cash-generative businesses such as pharmaceutical and medical-product distributors, managed-care providers, and insurers—segments that typically exhibit resilient demand regardless of the economic cycle.
The broader macroeconomic backdrop has favored stability-oriented portfolios. Moderating inflation, a Federal Reserve that has shifted toward a more measured stance on interest rates, and steady consumer spending have supported value and quality factors. At the same time, elevated valuations in higher-beta growth stocks have prompted rotation toward companies with durable earnings and lower volatility, a dynamic that generally benefits a multi-factor strategy like ONEV. Insurers and healthcare distributors, in particular, have benefited from disciplined pricing and consistent demand, reinforcing the fund's defensive profile. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the trailing 30 days, ONEV gained roughly 1.8%, a modest but positive move consistent with its low-volatility mandate. Over the trailing quarter, the fund was approximately flat, having drifted from the low-$150 range in late summer through a pullback into the high-$130s before recovering toward the mid-$150 area and settling near $150. This pattern reflects a range-bound rather than trend-driven market, with the fund's quality and low-volatility tilt muting both gains and losses.
The performance has been supported by strength among healthcare distributors and insurers, sectors in which ONEV maintains meaningful weight. Earnings seasons have generally favored large, cash-generative companies with predictable revenues, aligning with the fund's factor profile. Meanwhile, rising interest-rate sensitivity and periodic bouts of growth-stock volatility have reinforced investor demand for defensive, lower-beta exposure, helping the fund hold its ground relative to the broader large-cap market.
Several structural factors are likely to shape ONEV's performance during 2026. The path of monetary policy and interest-rate expectations remains central, as changes in yields influence the relative appeal of defensive, dividend-paying equities versus fixed income. The trajectory of inflation and economic growth will also matter, particularly for the fund's Industrials, Financials, and Healthcare exposures.
The earnings cycles of major holdings such as healthcare distributors and insurers are another key monitor, as pricing discipline, medical utilization trends, and catastrophe-loss experience can all affect profitability. Capital flows into low-volatility and quality factor strategies will influence demand for ONEV relative to competitors in the large-cap blend category. Finally, sector rotation between growth and value, alongside regulatory developments in healthcare and insurance, could present both risks and opportunities. Rather than predicting prices, investors should track these themes as the principal drivers of the fund's future behavior.
In my own analysis, Tickeron’s AI Screener has proven useful for quickly scanning large-cap equities and ETFs. It helps surface low-volatility or quality-oriented names that align with strategies like ONEV by applying filters for fundamentals, volatility, and sector exposure. This kind of tool supports more efficient comparison across defensive factor tilts without replacing deeper fundamental review.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
ONEV moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend. In 36 of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 84%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for ONEV crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 73%.
Following a +0.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where ONEV advanced for three days, in 244 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
ONEV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 209 of 293 cases where ONEV Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The 10-day RSI Indicator for ONEV moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 25 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ONEV as a result. In 60 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
The Moving Average Convergence Divergence Histogram (MACD) for ONEV turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 30 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONEV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows